AVDL
Avadel Pharmaceuticals
AVDL
AVDL
Delisted
AVDL was delisted on the 11th of February, 2026.
78 hedge funds and large institutions have $306M invested in Avadel Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 74 → 78 (+4)
0.39% less ownership
Funds ownership: 67.42% → 67.03% (-0.39%)
Holders
78
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$21.9M | |
| 2 | +$6.89M | |
| 3 | +$6.21M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.6M |
| 5 |
Morgan Stanley
New York
|
+$2.8M |
Top Sellers
| 1 | -$17.2M | |
| 2 | -$4.19M | |
| 3 | -$3.32M | |
| 4 |
BC
Broadfin Capital
New York
|
-$2.62M |
| 5 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$929K |